(Q45735792)

15 December 2017

title

Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology (English)

1 reference

15 December 2017

1 reference

15 December 2017

Openshaw PJ

1 reference

15 December 2017

Pennycook A

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

European Journal of Immunology

15 December 2017

published in

1 reference

15 December 2017

1 reference

15 December 2017

1 reference

15 December 2017

page(s)

2566-2573

1 reference

Vaccines and cytokine-mediated pathology in RSV infection

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Tumor necrosis factor: a master-regulator of leukocyte movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Distinct types of lung disease caused by functional subsets of antiviral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Tumor necrosis factor and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

TNFalpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Polymorphism of the 5'-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2566%3A%3AAID-IMMU2566%3E3.0.CO%3B2-L

10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference